• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Health journalists from Africa receive grants to report on COVID-19

Home > News

Health journalists from Africa receive grants to report on COVID-19

Researcher working in a laboratory setting
18 May 2022

During a pandemic, media plays a crucial role in communicating public health and policy information. When COVID-19 spread like wildfire in 2020, the role of media as the primary source of public information became more evident. However, as COVID-19 cases continued to scourge, journalists were faced with new challenges in their work.

Understanding how medical science works, knowing how to interpret scientific communications, and factchecking information in the middle of lockdowns became more important than ever. That is why DNDi Africa Regional office organized a journalist workshop in 2020 for 22 health reporters from 12 African countries. Participants were invited from Burkina Faso, Côte d’ Ivoire, Cameroon, Democratic Republic of Congo, Ethiopia, Ghana, Guinea, Kenya, Mali, Somalia, Sudan, Togo, and Uganda.  

The workshop was a hands-on opportunity to foster open discussions with a group of journalists who were already reporting on COVID-19. The objective of the sessions was to give health reporters some key information to better understand how medical research is conducted – especially COVID-19 research in Africa – and better inform their audience about these central issues.

Financed by the French embassy in Nairobi, the workshop was organized around the launch of the ANTICOV clinical trial, a large COVID-19 study organized in in 13 African countries and coordinated by 26 leading African and international R&D institutions. This trial served as an opportunity for reporters to engage with scientists involved in it and report on COVID-19 research activities.

After the workshop, the journalists applied for financial grants to cover health-related stories in their respective countries.

10 reporters were eventually awarded a travel grant to document stories around the clinical trials and COVID-19 research. The stories focused on the impact of the disease, demystifying diagnosis and treatment, and the role of African scientists in COVID-19 research.

Below are some of the stories that were published by the journalists:

  1. Ethiopian press – ‘COVID-19 as a big lesson to reform Africa’s health sector’
  2. Actualité CD (DRC) – RDC : l’impact de la Covid-19 sur la lutte contre la maladie du sommeil (avis des spécialistes)
  3. Univers Sciences (Guinea) – Guinée : les laboratoires de diagnostic équipés pour faire face aux épidémies dont le Coronavirus
  4. KTN News (Kenya) – Kenya’s journey towards human vaccine manufacturing | Health Watch
  5. Africa Blogging (Côte D’Ivoire) – Covid-19 : L’Afrique va-t-elle dompter la pandémie
  6. L’Essor (Mali) – Recherche: Le contrecoup de la COVID-19
  7. The Ethiopian Herald (Ethiopia) – Investing in own clinical trials, narrowing down vaccine inequalities
  8. Africa Blogging (Côte D’Ivoire) – Covid-19 : La Côte d’Ivoire est-elle guérie ?
  9. Science Watch Infos – Les maladies tropicales négligées :: Au top de leur délaissement au Cameroun
  10. Ghana News Agency – COVID-19 sparking Africa’s search for ‘homemade’ cure for other diseases

Photo credit: Lameck Ododo-DNDi

Read, watch, share

Loading...
Stories
16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

Publications
16 Jul 2026

DNDi 2025 Annual Report

Laboratory of Medicinal and Computational Chemistry (LQMC), São Paulo University USP, São Carlos Campus, São Paulo Brazil.
Press releases
13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security 

Chepokarial Rubben attentively cares for her five-year-old son, Romanu Kiptoo, at the kala-azar ward of Kacheliba Sub-County Referral Hospital in West Pokot County, Kenya. She gently soothes him, offering comfort as he endures the painful treatment for kala-azar.
Press releases
13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Press releases
8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Patricia, 44, from Area 44 in Lilongwe, Malawi, has lived with vision loss for 10 years following a late diagnosis of cryptococcal meningitis.
Stories
30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

Publications
29 Jun 2026

Advancing global health innovation through Europe-Africa collaboration

News
29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors 

VIEW ALL

Help neglected patients

To date, we have delivered fourteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license